Takeda Pharmaceutical’s takeover of Irish drug maker Shire in May 2018 boosted outbound mergers and acquisitions from Japan last year. Photo: EPA-EFE

Japan outpaces China in race for outbound mergers as trade war, capital controls weigh on deal flow

  • China was fourth worldwide with US$105.4 billion in deals, according to data provider Dealogic
  • Chinese companies among most active deal makers in Asia outside Japan, according to Mergermarket
Topic |   Mergers & Acquisitions

TOP PICKS

Takeda Pharmaceutical’s takeover of Irish drug maker Shire in May 2018 boosted outbound mergers and acquisitions from Japan last year. Photo: EPA-EFE
READ FULL ARTICLE